Given Imaging Ltd. GIVN, a world leader in GI medical devices and pioneer of capsule endoscopy, announced today that data from the largest European multicenter study of PillCam COLON 2 conducted to date
confirm that the second-generation PillCam COLON capsule has higher sensitivity for colorectal polyp detection than the first generation technology. Furthermore, the study's authors, led by Cristiano Spada, MD, concluded that PillCam COLON is an appropriate tool for visualizing the colon. The study, abstract #671, was presented Monday
at the American Society for Gastrointestinal Endoscopy Topic Forum at Digestive Disease Week (DDW), which took place earlier this week in Chicago.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in